Won Wong

Dr. Won Wong

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2019 in Cells
Verified
Journal Article
Open access
PDF file
CLChin-Yap Loh
Chin-Yap Loh
CYChai Jian Yi
Chai Jian Yi
TTTing Fang Tang
Ting Fang Tang
WWWon Wong
Won Wong
Gautam SethiGautam Sethi
Gautam Sethi
Chung Yeng LooiChung Yeng Looi
Chung Yeng Looi
Epithelial-to-Mesenchymal Transition (EMT) has been shown to be crucial in tumorigenesis where the EMT program enhances metastasis, chemoresistance and tumor stemness. Due to its emerging role as a pivotal driver of tumorigenesis, targeting EMT is of great therapeutic interest in counteracting metastasis and chemoresistance in cancer patients. The hallmark of EMT is the upregulation of N-cadherin followed by the downregulation of E-cadherin, and this process is regulated by a complex network of signaling pathways and transcription factors. In this review, we summarized the recent understanding of the roles of E- and N-cadherins in cancer invasion and metastasis as well as the crosstalk with other signaling pathways involved in EMT. We also highlighted a few natural compounds with potential anti-EMT property and outlined the future directions in the development of novel intervention in human cancer treatments. We have reviewed 287 published papers related to this topic and identified some of the challenges faced in translating the discovery work from bench to bedside.

1 March 2017 in Biotechnology Advances
Verified
Journal Article
Closed access
YMYves Paul Mbous
Yves Paul Mbous
MHMaan Hayyan
Maan Hayyan
AHAdeeb Hayyan
Adeeb Hayyan
WWWon Wong
Won Wong
MHMohd Ali Hashim
Mohd Ali Hashim
CLChung Yeng Looi
Chung Yeng Looi

9 November 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ASAlireza Saeidi
Alireza Saeidi
KZKeivan Zandi
Keivan Zandi
YCYi Ying Cheok
Yi Ying Cheok
HSHamidreza Saeidi
Hamidreza Saeidi
WWWon Wong
Won Wong
ESEsaki Muthu Shankar
Esaki Muthu Shankar
T-cell exhaustion is a phenomenon of dysfunction or physical elimination of antigen-specific T cells reported in human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections as well as cancer. Exhaustion appears to be often restricted to CD8+ T cells responses in the literature, although CD4+ T cells have also been reported to be functionally exhausted in certain chronic infections. Although our understanding of the molecular mechanisms associated with the transcriptional regulation of T-cell exhaustion is advancing, it is imperative to also explore the central mechanisms that control the altered expression patterns. Targeting metabolic dysfunctions with mitochondrion-targeted antioxidants are also expected to improve the antiviral functions of exhausted virus-specific CD8+ T cells. In addition, it is crucial to consider the contributions of mitochondrial biogenesis on T-cell exhaustion and how mitochondrial metabolism of T cells could be targeted whilst treating chronic viral infections. Here, we review the current understanding of cardinal features of T-cell exhaustion in chronic infections, and have attempted to focus on recent discoveries, potential strategies to reverse exhaustion and reinvigorate optimal protective immune responses in the host.

21 February 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
CLChin-Yap Loh
Chin-Yap Loh
AAAditya Arya
Aditya Arya
ANAhmed Fadhil Naema
Ahmed Fadhil Naema
WWWon Wong
Won Wong
GSGautam Sethi
Gautam Sethi
Chung Yeng LooiChung Yeng Looi
Chung Yeng Looi
Signal Transducer and Activator of Transcription (STAT) pathway is connected upstream with Janus kinases (JAK) family protein and capable of integrating inputs from different signaling pathways. Each family member plays unique functions in signal transduction and crucial in mediating cellular responses to different kind of cytokines. STAT family members notably STAT3 and STAT5 have been involved in cancer progression whereas STAT1 plays opposite role by suppressing tumor growth. Persistent STAT3/5 activation is known to promote chronic inflammation, which increases susceptibility of healthy cells to carcinogenesis. Here, we review the role of STATs in cancers and inflammation while discussing current therapeutic implications in different cancers and test models, especially the delivery of STAT3/5 targeting siRNA using nanoparticulate delivery system.

29 June 2016 in SpringerPlus
Verified
Journal Article
Open access
PDF file
MHMaan Hayyan
Maan Hayyan
YMYves Paul Mbous
Yves Paul Mbous
CLChung Yeng Looi
Chung Yeng Looi
WWWon Wong
Won Wong
AHAdeeb Hayyan
Adeeb Hayyan
OMOzair Mohd-Ali
Ozair Mohd-Ali
The purpose of this study was to investigate the cytotoxic profiles of different ternary natural deep eutectic solvents (NADESs) containing water. For this purpose, five different NADESs were prepared using choline chloride as a salt, alongside five hydrogen bond donors (HBD) namely glucose, fructose, sucrose, glycerol, and malonic acid. Water was added as a tertiary component during the eutectics preparation, except for the malonic acid-based mixture. Coincidentally, the latter was found to be more toxic than any of the water-based NADESs. A trend was observed between the cellular requirements of cancer cells, the viscosity of the NADESs, and their cytotoxicity. This study also highlights the first time application of the conductor-like screening model for real solvent (COSMO-RS) software for the analysis of the cytotoxic mechanism of NADESs. COSMO-RS simulation of the interactions between NADESs and cellular membranes’ phospholipids suggested that NADESs strongly interacted with cell surfaces and that their accumulation and aggregation possibly defined their cytotoxicity. This reinforced the idea that careful selection of NADESs components is necessary, as it becomes evident that organic acids as HBD highly contribute to the increasing toxicity of these neoteric mixtures. Nevertheless, NADESs in general seem to possess relatively less acute toxicity profiles than their DESs parents. This opens the door for future large scale utilization of these mixtures.

10 June 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
PCPei Pei Chong
Pei Pei Chong
VCVoon Kin Chin
Voon Kin Chin
CLChung Yeng Looi
Chung Yeng Looi
WWWon Wong
Won Wong
PMPriya Madhavan
Priya Madhavan
VYVoon Chen Yong
Voon Chen Yong
Irritable bowel syndrome (IBS) is a functional disorder which affects a large proportion of the population globally. The precise etiology of IBS is still unknown, although consensus understanding proposes IBS to be of multifactorial origin with yet undefined subtypes. Genetic and epigenetic factors, stress-related nervous and endocrine systems, immune dysregulation and the brain-gut axis seem to be contributing factors that predispose individuals to IBS. In addition to food hypersensitivity, toxins and adverse life events, chronic infections and dysbiotic gut microbiota have been suggested to trigger IBS symptoms in tandem with the predisposing factors. This review will summarize the pathophysiology of IBS and the role of gut microbiota in relation to IBS. Current methodologies for microbiome studies in IBS such as genome sequencing, metagenomics, culturomics and animal models will be discussed. The myriad of therapy options such as immunoglobulins (immune-based therapy), probiotics and prebiotics, dietary modifications including FODMAP restriction diet and gluten-free diet, as well as fecal transplantation will be reviewed. Finally this review will highlight future directions in IBS therapy research, including identification of new molecular targets, application of 3-D gut model, gut-on-a-chip and personalized therapy.